Collaborative Scientific Opportunities Between All of Us: Computational Science in Immuno-Oncology
In partnership with NCI’s Cancer MoonshotSM Initiative, the Society for Immunotherapy of Cancer (SITC) and the Big Data and Data Sharing Committee are hosting the ninth and final webinar that makes up the 2022 SITC-NCI Computational Immuno-Oncology Webinar Series. Dr. Sheri Schully of NIH’s All of Us Research Program will present, “Collaborative Scientific Opportunities Between All of Us: Computational Science in Immuno-Oncology” with moderation by NCI’s Dr. Lillian Kuo.
The SITC-NCI Computational Immuno-Oncology Webinar Series consists of nine, hour-long courses featuring a moderator and faculty speaker to lead instruction. Topics will cover a host of computational challenges of analyzing and integrating diverse assay data across the spectrum of immuno-oncology. This series is intended for scientists early in their careers and/or those who want to remain abreast of the latest technologies. These webinars were created to foster better communication concerning data science technologies and analyses between cancer immunotherapy researchers and clinicians to advance translational immunotherapy research.
Dr. Schully is deputy chief medical and scientific officer of the All of Us Research Program at NIH.
Dr. Kuo is a program director for NCI’s Cancer Immunology, Hematology, and Etiology Branch in the Division of Cancer Biology.
Upcoming Events
- Envisioning a Future Toward More Equitable Trials: Artificial Intelligence and Its Implications in Health EquitySeptember 09, 2024 - September 10, 2024Impact of the Molecular Characterization Initiative on Pediatric CNS TumorsSeptember 10, 2024AI and Global OncologySeptember 24, 2024NCI’s Clinical and Translational Data Commons: Your Resource for Cancer DiscoverySeptember 25, 2024NCI Office of Data Sharing’s Annual Data Sharing Symposium: Driving Cancer Advances Through Impactful ResearchOctober 16, 2024The Cancer Research Data Commons 2024 Fall Symposium: Ten Years of Empowering Cancer ResearchersOctober 16, 2024 - October 17, 2024